Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Minimal Residual Disease Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia

NCT01385787 is registered in ClinicalTrials.gov with Center for International Blood and Marrow Transplant Research as lead sponsor.

NCT NCT01385787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01385787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Minimal Residual Disease Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia
Lead sponsor
Center for International Blood and Marrow Transplant Research
Phase
Observational
Overall status
Completed
Start date
October 31, 2011
Completion date
May 31, 2017
Enrollment
150 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia